COVID-19 Epidemiology in Türkiye
The World Health Organization declared the current pandemic, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, which began in China in December 2019. SARS-CoV-2 has the third highest recorded pathogenicity, with mortality rates varying from 6 to 10.5% based on comorbid...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/87988 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | The World Health Organization declared the current pandemic, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, which began in China in December 2019. SARS-CoV-2 has the third highest recorded pathogenicity, with mortality rates varying from 6 to 10.5% based on comorbidity of the individual infected with the virus. Epidemiologic studies have critical importance in the fight against any disease. This chapter discusses demographic and epidemiologic literature data including age, gender, reinfection, death, and vaccination rates reported in numerous articles during the pandemic process from Türkiye. |
|---|---|
| ISBN: | 978-1-80356-746-4 |
| DOI: | 10.5772/intechopen.112664 |